copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
eCTD Backbone File Specification for Modules 2 through 5-3 The structure and level of detail specified in the CTD have been used as the basis for defining the eCTD structure and content but, where appropriate, additional details have been developed
eCTD Guidance v4 0-20160318-hv - Europa Guidance on the placement of documents within the eCTD structure for particular submission types can be found in the EU-CTD Notice to Applicants and or in the EMA post-authorisation guidance for centralised applications
What are the Clinical Components of the eCTD? - waysps. com Module 5, the clinical section of the eCTD, includes detailed reports of clinical trials and studies related to biopharmaceutics, pharmacokinetics, pharmacodynamics, efficacy, and safety, along with individual study reports and patient data
M4E(R2): The CTD Efficacy Guidance for Industry Guidance on the Efficacy section of the CTD (Module 2, the Clinical Overview and the Clinical Summary, and Module 5) can be found in the guidance for industry M4E: The CTD — Efficacy
!4539E2. PDF - U. S. Food and Drug Administration In this guidance for industry, sections that should be included in Module 2 and Module 5 of the CTD have been numbered using the Arabic numbers 2 and 5, respectively
Recommended Contents of a Sample eCTD Submission Include one study in section 5 3 1 1, 5 3 1 2, 5 3 3 1, 5 3 3 2, 5 3 3 3, 5 3 3 4, 5 3 4, 5 3 5 1, or 5 3 5 2 the ICH Implementation Guide, the controlled vocabulary, and the
Microsoft PowerPoint - eCTD_Pharmexcil_06_05_2011. ppt [Compatibility Mode] “The eCTD is defined as an interface for industry to agency transfer of regulatory information while at the same time taking into consideration the facilitation of the creation, review, lifecycle management and archival of the electronic submission ”